Group One Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,700
| Closed | -$7K | – | 9277 |
|
|
2021
Q3 | $7K | Buy |
1,700
+700
| +70% | +$2.78K | ﹤0.01% | 7669 |
|
|
2021
Q2 | $4K | Sell |
1,000
-1,900
| -66% | -$8.14K | ﹤0.01% | 7855 |
|
|
2021
Q1 | $12K | Buy |
2,900
+2,600
| +867% | +$14.3K | ﹤0.01% | 6994 |
|
|
2020
Q4 | $1K | Sell |
300
-200
| -40% | -$855 | ﹤0.01% | 6395 |
|
|
2020
Q3 | $2K | Sell |
500
-1,200
| -71% | -$4.97K | ﹤0.01% | 5890 |
|
|
2020
Q2 | $7K | Sell |
1,700
-5,200
| -75% | -$31.7K | ﹤0.01% | 5296 |
|
|
2020
Q1 | $29K | Buy |
6,900
+4,400
| +176% | +$27.8K | ﹤0.01% | 4054 |
|
|
2019
Q4 | $10K | Buy |
2,500
+2,300
| +1,150% | +$13.6K | ﹤0.01% | 4624 |
|
|
2019
Q3 | $2K | Sell |
200
-3,700
| -95% | -$35K | ﹤0.01% | 4961 |
|
|
2019
Q2 | $36K | Buy |
3,900
+3,600
| +1,200% | +$27.1K | ﹤0.01% | 3948 |
|
|
2019
Q1 | $2K | Buy |
+300
| New | +$1.95K | ﹤0.01% | 4637 |
|
|
2018
Q3 | – | Sell |
-2,000
| Closed | -$58K | – | 6035 |
|
|
2018
Q2 | $58K | Sell |
2,000
-9,800
| -83% | -$303K | ﹤0.01% | 3874 |
|
|
2018
Q1 | $351K | Sell |
11,800
-12,100
| -51% | -$390K | ﹤0.01% | 2330 |
|
|
2017
Q4 | $769K | Sell |
23,900
-35,900
| -60% | -$1.17M | 0.01% | 1921 |
|
|
2017
Q3 | $2.08M | Buy |
59,800
+5,500
| +10% | +$177K | 0.02% | 1019 |
|
|
2017
Q2 | $1.62M | Buy |
54,300
+2,700
| +5% | +$77.4K | 0.02% | 1094 |
|
|
2017
Q1 | $1.54M | Buy |
51,600
+40,900
| +382% | +$1.04M | 0.02% | 1038 |
|
|
2016
Q4 | $188K | Buy |
10,700
+10,100
| +1,683% | +$194K | ﹤0.01% | 2475 |
|
|
2016
Q3 | $14K | Sell |
600
-31,100
| -98% | -$586K | ﹤0.01% | 3950 |
|
|
2016
Q2 | $507K | Buy |
+31,700
| New | +$569K | 0.01% | 1725 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$27K | – | 5578 |
|
|
2015
Q4 | $27K | Sell |
1,000
-17,700
| -95% | -$483K | ﹤0.01% | 3770 |
|
|
2015
Q3 | $520K | Buy |
18,700
+15,300
| +450% | +$482K | 0.01% | 1754 |
|
|
2015
Q2 | $83K | Buy |
3,400
+2,300
| +209% | +$47.4K | ﹤0.01% | 3206 |
|
|
2015
Q1 | $20K | Sell |
1,100
-3,200
| -74% | -$64.9K | ﹤0.01% | 3901 |
|
|
2014
Q4 | $79K | Buy |
+4,300
| New | +$51K | ﹤0.01% | 3039 |
|
Group One Trading's LJPC Position: Q3 2022 in Review
Group One Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 333 shares — an estimated $1K sold.
Group One Trading first reported a position in LJPC in Q2 2015 and held it in 19 quarters. The position peaked at $366K in Q3 2015. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Group One Trading reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 333 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $1K.
- Group One Trading first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 19 quarters.
- Group One Trading's La Jolla Pharmaceutical Company position peaked at $366K in Q3 2015.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.